R Scott Huennekens's most recent trade in Envista Holdings Corp was a trade of 14,370 Common Stock done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 14,370 | 69,520 (0%) | 0% | 0 | Common Stock | |
| NeuroPace Inc | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 8,745 | 8,745 | - | - | Stock Option (right to buy) | |
| QuidelOrtho Corporation | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,829 | 6,829 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 2,523 | 2,523 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Richard Scott Huennekens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 2,523 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| NeuroPace Inc | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 15,507 | 15,507 | - | - | Stock Option (Right to Buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 12 Jun 2024 | 79,200 | 79,200 | - | - | Stock Options (right to buy) | ||
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 14,170 | 55,150 (0%) | 0% | 0 | Common Stock | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 25,480 | 25,480 | - | - | FORM 4 | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,920 | 21,840 | - | 0 | FORM 4 | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 09 Jun 2023 | 237,437 | 0 | - | - | Stock Options (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 09 Jun 2023 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 09 Jun 2023 | 112,000 | 112,000 | - | - | Stock Options (right to buy) | ||
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 7,625 | 40,980 (0%) | 0% | 0 | Common Stock | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 712,312 | 0 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 712,312 | 712,312 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 237,437 | 0 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 237,437 | 0 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 31 Oct 2022 | 237,437 | 0 | - | - | Stock Option (right to buy) | ||
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 5,880 | 5,880 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 2,520 | 10,920 | - | 0 | Common Stock | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 8,400 | - | 0 | Common Stock | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 09 Jun 2022 | 85,345 | 85,345 | - | - | Stock Options (right to buy) | ||
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 5,930 | 33,355 (0%) | 0% | 0 | Common Stock | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 29 Mar 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 22 Dec 2021 | 712,312 | 712,312 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 22 Dec 2021 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 22 Dec 2021 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | ||
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | 22 Dec 2021 | 19,586 | 19,586 | - | 0 | Class A Common Stock | ||
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,455 | 27,425 (0%) | 0% | 0 | Common Stock |